{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:29:10Z","timestamp":1791271750164,"version":"4.1.0"},"reference-count":257,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Over the years, the relationship between high-density lipoprotein (HDL) and atherosclerosis, initially highlighted by the Framingham study, has been revealed to be extremely complex, due to the multiple HDL functions involved in atheroprotection. Among them, HDL cholesterol efflux capacity (CEC), the ability of HDL to promote cell cholesterol efflux from cells, has emerged as a better predictor of cardiovascular (CV) risk compared to merely plasma HDL-cholesterol (HDL-C) levels. HDL CEC is impaired in many genetic and pathological conditions associated to high CV risk such as dyslipidemia, chronic kidney disease, diabetes, inflammatory and autoimmune diseases, endocrine disorders, etc. The present review describes the current knowledge on HDL CEC modifications in these conditions, focusing on the most recent human studies and on genetic and pathophysiologic aspects. In addition, the most relevant strategies possibly modulating HDL CEC, including lifestyle modifications, as well as nutraceutical and pharmacological interventions, will be discussed. The objective of this review is to help understanding whether, from the current evidence, HDL CEC may be considered as a valid biomarker of CV risk and a potential pharmacological target for novel therapeutic approaches.<\/jats:p>","DOI":"10.3390\/cells10030574","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T11:46:09Z","timestamp":1614944769000},"page":"574","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives"],"prefix":"10.3390","volume":"10","author":[{"given":"Maria Pia","family":"Adorni","sequence":"first","affiliation":[{"name":"Unit of Neurosciences, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Ronda","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Bernini","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6665-263X","authenticated-orcid":false,"given":"Francesca","family":"Zimetti","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9149(80)90516-0","article-title":"Prevalence of coronary heart disease in the Framingham Offspring Study: Role of lipoprotein cholesterols","volume":"46","author":"Wilson","year":"1980","journal-title":"Am. J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: Two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-319-09665-0_4","article-title":"Cholesterol efflux and reverse cholesterol transport","volume":"224","author":"Favari","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and Reverse Cholesterol Transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"24020","DOI":"10.1074\/jbc.R114.583658","article-title":"Molecular mechanisms of cellular cholesterol efflux","volume":"289","author":"Phillips","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jacl.2018.09.005","article-title":"JCL roundtable: High-density lipoprotein function and reverse cholesterol transport","volume":"12","author":"Cuchel","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2020.04.015","article-title":"High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta-analysis","volume":"302","author":"Grau","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-2275(20)39245-2","article-title":"Role of plasma lecithin:cholesterol acyltransferase in the metabolism of high density lipoproteins","volume":"7","author":"Glomset","year":"1966","journal-title":"J. Lipid Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","article-title":"Macrophage Reverse Cholesterol Transport: Key to the Regression of Atherosclerosis?","volume":"113","author":"Cuchel","year":"2006","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/138920112799095383","article-title":"Cellular Cholesterol Efflux Pathways: Impact on Intracellular Lipid Trafficking and Methodological Considerations","volume":"13","author":"Zanotti","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.plipres.2017.12.001","article-title":"Determinants of cholesterol efflux capacity in humans","volume":"69","author":"Talbot","year":"2018","journal-title":"Prog. Lipid Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1194\/jlr.RA119000258","article-title":"Composition-function analysis of HDL subpopulations: Influence of lipid composition on particle functionality","volume":"61","author":"Niisuke","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5551\/jat.32854","article-title":"Role of LCAT in Atherosclerosis","volume":"23","author":"Ossoli","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1074\/jbc.271.4.2023","article-title":"Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange","volume":"271","author":"Czarnecka","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/CIRCULATIONAHA.108.825109","article-title":"Lecithin: Cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo","volume":"120","author":"Tanigawa","year":"2009","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2008.08.038","article-title":"Functional LCAT is not required for macrophage cholesterol efflux to human serum","volume":"204","author":"Calabresi","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma cholesteryl ester transfer protein","volume":"34","author":"Tall","year":"1993","journal-title":"J. Lipid Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: A novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1194\/jlr.R800088-JLR200","article-title":"The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis","volume":"50","author":"Rader","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/ATVBAHA.119.312382","article-title":"Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor","volume":"39","author":"Bashore","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/CIRCRESAHA.119.316424","article-title":"LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models","volume":"127","author":"Metso","year":"2020","journal-title":"Circ. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"16237","DOI":"10.1073\/pnas.252582399","article-title":"Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion","volume":"99","author":"Yu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/ATVBAHA.113.301562","article-title":"Role the TICE?: Advancing the concept of transintestinal cholesterol excretion","volume":"33","author":"Tietge","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-physiol-021317-121550","article-title":"SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux","volume":"80","author":"Shen","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MOL.0b013e32833dedaa","article-title":"Relative roles of various efflux pathways in net cholesterol efflux from macrophage foam cells in atherosclerotic lesions","volume":"21","author":"Zhao","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Jebari-Benslaiman, S., Uribe, K.B., Benito-Vicente, A., Galicia-Garcia, U., Larrea-Sebal, A., Alloza, I., Vandenbroeck, K., Ostolaza, H., and Mart\u00edn, C. (2020). Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition. Biomedicines, 8.","DOI":"10.3390\/biomedicines8100373"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1021\/bi901564g","article-title":"Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1","volume":"48","author":"Favari","year":"2009","journal-title":"Biochemistry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1194\/jlr.M700274-JLR200","article-title":"The roles of different pathways in the release of cholesterol from macrophages","volume":"48","author":"Adorni","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2017.01.034","article-title":"SR-BI as target in atherosclerosis and cardiovascular disease\u2014A comprehensive appraisal of the cellular functions of SR-BI in physiology and disease","volume":"258","author":"Hoekstra","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.cell.2017.05.020","article-title":"Structure of the Human Lipid Exporter ABCA1","volume":"169","author":"Qian","year":"2017","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2796.2007.01898.x","article-title":"Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins","volume":"263","author":"Tall","year":"2008","journal-title":"J. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1074\/jbc.M312476200","article-title":"Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein","volume":"279","author":"Favari","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-981-15-6082-8_6","article-title":"ABC Transporters, Cholesterol Efflux, and Implications for Cardiovascular Diseases","volume":"1276","author":"Wang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/01.ATV.18.9.1417","article-title":"Human apolipoproteins A-I and A-II in cell cholesterol efflux: Studies with transgenic mice","volume":"18","author":"Chiesa","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ayaori, M., and Ikewaki, K. (2014). Role of ATP-Binding Cassette Transporters A1 and G1 in Reverse Cholesterol Transport and Atherosclerosis, Elsevier. [2nd ed.].","DOI":"10.1016\/B978-0-12-407867-3.00005-6"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1042\/bst0320124","article-title":"ATP-binding cassette transporter A1: Regulation of cholesterol efflux","volume":"32","author":"Knight","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2011.04.010","article-title":"Genetic variation in ABCA1 and risk of cardiovascular disease","volume":"218","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00041433-200208000-00004","article-title":"ATP-binding cassette transporter A1 and cholesterol trafficking","volume":"13","author":"Oram","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/pr.119.017897","article-title":"Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment","volume":"72","author":"Frambach","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1073\/pnas.0237205100","article-title":"Role of ABC transporters in secretion of cholesterol from liver into bile","volume":"100","author":"Small","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/ATVBAHA.109.194548","article-title":"Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent","volume":"29","author":"Larrede","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Hardy, L.M., Frisdal, E., and le Goff, W. (2017). Critical Role of the Human ATP-Binding Cassette G1 Transporter in Cardiometabolic Diseases. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18091892"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/hc0302.102575","article-title":"Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular M\u00fcnster (PROCAM) study","volume":"105","author":"Assmann","year":"2002","journal-title":"Circulation"},{"key":"ref_52","first-page":"538","article-title":"The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients (AIM-HIGH) trial","volume":"161","year":"2011","journal-title":"Am. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density","volume":"299","author":"Nordestgaard","year":"2008","journal-title":"JAMA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1373\/clinchem.2016.257725","article-title":"The changing face of HDL and the best way to measure it","volume":"63","author":"Karathanasis","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5551\/jat.RV17028","article-title":"Assessment of HDL cholesterol removal capacity: Toward clinical application","volume":"26","author":"Toh","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.109.199158","article-title":"The Ability to Promote Efflux via ABCA1 Determines the Capacity of Serum Specimens with Similar HDL-C to Remove Cholesterol from Macrophages","volume":"30","author":"Asztalos","year":"2010","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1074\/jbc.M609336200","article-title":"A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-IMilano dimer effectively promotes ATP-binding cassette A1-mediated cell cholesterol efflux","volume":"282","author":"Favari","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","article-title":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: A prospective case-control study","volume":"3","author":"Saleheen","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2015.06.028","article-title":"High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease","volume":"242","author":"Ishikawa","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/ATVBAHA.115.306665","article-title":"Association between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia","volume":"36","author":"Ogura","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/eurjhf\/hft084","article-title":"Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy","volume":"15","author":"Patel","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12944-017-0604-5","article-title":"High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: A systematic review and meta-analysis","volume":"16","author":"Qiu","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12944-020-01260-4","article-title":"HDL functions and their interaction in patients with ST elevation myocardial infarction: A case control study","volume":"19","author":"Thakkar","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1194\/jlr.P030452","article-title":"ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects","volume":"54","author":"Favari","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.numecd.2014.02.010","article-title":"Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia","volume":"24","author":"Vigna","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1161\/ATVBAHA.115.305504","article-title":"High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease","volume":"35","author":"Agarwala","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2016.08.038","article-title":"High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study","volume":"68","author":"Ko","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacl.2019.10.012","article-title":"High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study","volume":"14","author":"Josefs","year":"2020","journal-title":"J. Clin. Lipidol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","article-title":"Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1161\/ATVBAHA.119.312645","article-title":"HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population","volume":"39","author":"Ebtehaj","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1161\/CIRCULATIONAHA.116.025678","article-title":"Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)","volume":"135","author":"Khera","year":"2017","journal-title":"Circulation"},{"key":"ref_73","first-page":"1870","article-title":"HDL cholesterol efflux capacity and cardiovascular events","volume":"372","author":"Ritsch","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_74","first-page":"698","article-title":"Impaired Renal Function on Cholesterol Efflux Capacity, HDL particle Number and Cardiovascular Events","volume":"72","author":"Chindhy","year":"2018","journal-title":"JAMA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.healun.2016.06.022","article-title":"Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients","volume":"35","author":"Javaheri","year":"2016","journal-title":"J. Hear. Lung Transplant. Off. Publ. Int. Soc. Hear. Transplant."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.2016030262","article-title":"HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients","volume":"28","author":"Kopecky","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2015.10.111","article-title":"Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study","volume":"249","author":"Liu","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.jacc.2016.03.538","article-title":"Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction","volume":"67","author":"Mody","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Soria-Florido, M.T., Casta\u00f1er, O., Lassale, C., Estruch, R., Salas-Salvad\u00f3, J., Mart\u00ednez-Gonz\u00e1lez, M.\u00c1., Corella, D., Ros, E., Ar\u00f3s, F., and Elosua, R. (2020). Dysfunctional High-Density Lipoproteins Are Associated with a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study. Circulation, 444\u2013453.","DOI":"10.1161\/CIRCULATIONAHA.119.041658"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Riggs, K.A., Joshi, P.H., Khera, A., Singh, K., Akinmolayemi, O., Ayers, C.R., and Rohatgi, A. (2019). Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events. J. Clin. Med., 8.","DOI":"10.3390\/jcm8122137"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2020.10.006","article-title":"Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!","volume":"159","author":"Nazir","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.2014090857","article-title":"HDL cholesterol efflux predicts graft failure in renal transplant recipients","volume":"27","author":"Annema","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/ATVBAHA.118.311366","article-title":"Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque","volume":"39","author":"Shea","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2020.02.007","article-title":"Cholesterol mass efflux capacity and risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis","volume":"297","author":"Garg","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_85","unstructured":"Rader, D.J., and Hobbs, H.H. (2008). Disorders of Lipoprotein Metabolism. Harrison\u2019s Princ. Intern. Med., 2416\u20132429."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.113.300634","article-title":"Mendelian disorders of high-density lipoprotein metabolism","volume":"114","author":"Oldoni","year":"2014","journal-title":"Circ. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI109956","article-title":"A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family","volume":"66","author":"Franceschini","year":"1980","journal-title":"J. Clin. Investig."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.103.15.1949","article-title":"Cardiovascular status of carriers of the apolipoprotein A-IMilano mutant: The limone sul garda study","volume":"103","author":"Sirtori","year":"2001","journal-title":"Circulation"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Nilsson, O., Lindvall, M., Obici, L., Ekstr\u00f6m, S., Lagerstedt, J.O., and del Giudice, R. (2020). Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux. J. Lipid Res., 1\u201336.","DOI":"10.1101\/2020.04.08.031211"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Gkolfinopoulou, C., Bourtsala, A., and Chroni, A. (2020). Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I. Biochim. Biophys. Acta\u2014Mol. Cell Biol. Lipids, 1865.","DOI":"10.1016\/j.bbalip.2019.158593"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jacl.2015.09.001","article-title":"A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla)","volume":"9","author":"Pisciotta","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1194\/jlr.M002113","article-title":"Disruption of the C-terminal helix by single amino acid deletion is directly responsible for impaired cholesterol effl ux ability of apolipoprotein A-I Nichinan","volume":"51","author":"Kono","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2015.02.005","article-title":"Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux","volume":"9","author":"Anthanont","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0022-2275(20)37205-9","article-title":"A natural apolipoprotein A-I variant, apoA-I(L141R)(Pisa), interferes with the formation of \u03b1-high density lipoproteins (HDL) but not with the formation of pr\u03b21-HDL and influences efflux of cholesterol into plasma","volume":"38","author":"Miccoli","year":"1997","journal-title":"J. Lipid Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-2275(20)37281-3","article-title":"Heterozygosity for apolipoprotein A-I(R160L)(Oslo) is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA- I\/A-II but normal levels of HDL-subclass LpA-I","volume":"38","author":"Leren","year":"1997","journal-title":"J. Lipid Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI114355","article-title":"Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I","volume":"84","author":"Funke","year":"1989","journal-title":"J. Clin. Investig."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2011.11.034","article-title":"Genetic lecithin: Cholesterol acyltransferase deficiency and cardiovascular disease","volume":"222","author":"Calabresi","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1194\/jlr.M600403-JLR200","article-title":"Role of LCAT in HDL remodeling: Investigation of LCAT deficiency states","volume":"48","author":"Asztalos","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0009-8981(01)00689-1","article-title":"A normal rate of cellular cholesterol removal can be mediated by plasma from a patient with familial lecithin-cholesterol acyltransferase (LCAT) deficiency","volume":"314","author":"Clerc","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199011013231803","article-title":"Increased High-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation","volume":"323","author":"Inazu","year":"1990","journal-title":"New English J. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbalip.2014.07.015","article-title":"HDL and atherosclerosis: Insights from inherited HDL disorders","volume":"1851","author":"Calabresi","year":"2015","journal-title":"Biochim. Biophys. Acta\u2014Mol. Cell Biol. Lipids"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.atherosclerosis.2009.01.006","article-title":"A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred","volume":"205","author":"Calabresi","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2008.12.012","article-title":"Cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells to serum is preserved in CETP-deficient patients","volume":"402","author":"Miwa","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.atherosclerosis.2011.01.051","article-title":"CETP deficiency due to a novel mutation in the CETP gene promoter and its effect on cholesterol efflux and selective uptake into hepatocytes","volume":"216","author":"Plengpanich","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa0907687","article-title":"Genetic Variant of the Scavenger Receptor BI in Humans","volume":"364","author":"Vergeer","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Chadwick, A.C., and Sahoo, D. (2012). Functional Characterization of Newly-Discovered Mutations in Human SR-BI. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045660"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/jn\/136.4.877","article-title":"Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux","volume":"136","author":"Ottestad","year":"2006","journal-title":"J. Nutr."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/ATVBAHA.111.227181","article-title":"Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia","volume":"31","author":"Bellanger","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/eci.12643","article-title":"Familial hypercholesterolaemia: Cholesterol efflux and coronary disease","volume":"46","author":"Versmissen","year":"2016","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1016\/S0021-9258(19)40786-2","article-title":"Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease","volume":"250","author":"Goldstein","year":"1975","journal-title":"J. Biol. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase de fi ciency e An under-recognized cause of dyslipidaemia and liver dysfunction","volume":"235","author":"Guardamagna","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.atherosclerosis.2015.08.007","article-title":"Cholesterol traf fi cking-related serum lipoprotein functions in children with cholesteryl ester storage disease","volume":"242","author":"Zimetti","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Shimamura, M., Matsuda, M., Yasumo, H., Okazaki, M., Fujimoto, K., Kono, K., Shimizugawa, T., Ando, Y., Koishi, R., and Kohama, T. (2007). Angiopoietin-Like Protein3 Regulates Plasma HDL Cholesterol Through Suppression of Endothelial Lipase Mitsuru. Arter. Thromb. Vasc. Biol., 366\u2013372.","DOI":"10.1161\/01.ATV.0000252827.51626.89"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","article-title":"Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia","volume":"363","author":"Musunuru","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCGENETICS.111.960674","article-title":"Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3","volume":"5","author":"Pisciotta","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.ijcard.2013.05.053","article-title":"Functional and morphological vascular changes in subjects with familial combined hypolipidemia: An exploratory analysis","volume":"168","author":"Minicocci","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Podkowi\u0144ska, A., and Formanowicz, D. (2020). Chronic kidney disease as oxidative stress-and inflammatory-mediated cardiovascular disease. Antioxidants, 9.","DOI":"10.3390\/antiox9080752"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Rysz, J., Gluba-Brz\u00f3zka, A., Rysz-G\u00f3rzy\u0144ska, M., and Franczyk, B. (2020). The role and function of HDL in patients with chronic kidney disease and the risk of cardiovascular disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020601"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1681\/ASN.2014030309","article-title":"Dialysis Modalities and HDL Composition and Function","volume":"26","author":"Holzer","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2012.09.013","article-title":"Dysfunctional high-density lipoprotein in patients on chronic hemodialysis","volume":"60","author":"Yamamoto","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2015.06.005","article-title":"Effect of chronic kidney disease on macrophage cholesterol efflux","volume":"136","author":"Meier","year":"2015","journal-title":"Life Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2215\/CJN.11321017","article-title":"Alteration of HDL Protein Composition with Hemodialysis Initiation","volume":"13","author":"Wang","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1194\/jlr.M004085","article-title":"Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export","volume":"51","author":"Shao","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ekir.2019.11.003","article-title":"Impaired Delivery of Cholesterol Effluxed From Macrophages to Hepatocytes by Serum From CKD Patients May Underlie Increased Cardiovascular Disease Risk","volume":"5","author":"Gipson","year":"2020","journal-title":"Kidney Int. Reports"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Stadler, J.T., and Marsche, G. (2020). Obesity-related changes in high-density lipoprotein metabolism and function. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21238985"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2018.04.029","article-title":"HDL cholesterol efflux capacity and cholesteryl ester transfer are associated with body mass, but are not changed by diet-induced weight loss: A randomized trial in abdominally obese men","volume":"274","author":"Talbot","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1210\/jc.2017-00933","article-title":"Adiponectin predicts high-density lipoprotein cholesterol efflux capacity in adults irrespective of body mass index and fat distribution","volume":"102","author":"Marsche","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.amjcard.2011.10.008","article-title":"High-density lipoprotein cholesterol efflux, nitration of apolipoprotein A-I, and endothelial function in obese women","volume":"109","author":"Vazquez","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-Term Mortality After Gastric Bypass Surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacl.2017.10.007","article-title":"Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA\/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity","volume":"12","author":"Kjellmo","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jc.2010-2378","article-title":"Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women","volume":"96","author":"Julia","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Lorkowski, S.W., Brubaker, G., Rotroff, D.M., Kashyap, S.R., Bhatt, D.L., Nissen, S.E., Schauer, P.R., Aminian, A., and Smith, J.D. (2020). Bariatric surgery improves hdl function examined by apoa1 exchange rate and cholesterol efflux capacity in patients with obesity and type 2 diabetes. Biomolecules, 10.","DOI":"10.3390\/biom10040551"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/ATVBAHA.117.310102","article-title":"Changes in HDL Cholesterol Efflux Capacity following Bariatric Surgery are Procedure Dependent","volume":"38","author":"Heffron","year":"2018","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.131491","article-title":"Structure-function relationships of HDL in diabetes and coronary heart disease","volume":"5","author":"Cardner","year":"2020","journal-title":"JCI Insight"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Wong, N.K.P., Nicholls, S.J., Tan, J.T.M., and Bursill, C.A. (2018). The role of high-density lipoproteins in diabetes and its vascular complications. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061680"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/ATVBAHA.116.307385","article-title":"Impaired cholesterol efflux capacity of high-density lipoprotein isolated from interstitial fluid in type 2 diabetes mellitus\u2014brief report","volume":"36","author":"Apro","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2017.05.031","article-title":"Pre-\u03b21 HDL in type 2 diabetes mellitus","volume":"263","author":"Shiu","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"He, Y., Ronsein, G.E., Tang, C., Jarvik, G.P., Davidson, W.S., Kothari, V., Song, H.D., Segrest, J.P., Bornfeldt, K.E., and Heinecke, J.W. (2020). Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles. Circ. Res., 1198\u20131210.","DOI":"10.1161\/CIRCRESAHA.120.317178"},{"key":"ref_141","first-page":"1","article-title":"HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: From the CORDIOPREV trial","volume":"7","author":"Camargo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/jcp.24860","article-title":"In Type 2 Diabetes Mellitus Glycated Albumin Alters Macrophage Gene Expression Impairing ABCA1-Mediated Cholesterol Efflux","volume":"230","author":"Iborra","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Dullaart, R.P.F., Pagano, S., Perton, F.G., and Vuilleumier, N. (2019). Antibodies against the C-terminus of ApoA-1 are inversely associated with cholesterol efflux capacity and HDL metabolism in subjects with and without type 2 diabetes mellitus. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030732"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.atherosclerosis.2012.03.037","article-title":"Pancreatic \u03b2-cell function relates positively to HDL functionality in well-controlled Type 2 diabetes mellitus","volume":"222","author":"Dullaart","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jacl.2011.06.016","article-title":"Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus","volume":"5","author":"Tan","year":"2011","journal-title":"J. Clin. Lipidol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.atherosclerosis.2006.12.027","article-title":"Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre \u03b2-HDL, phospholipid transfer protein and cholesterol esterification","volume":"196","author":"Groen","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/dmrr.2362","article-title":"Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1- mediated reverse cholesterol transport","volume":"29","author":"Iborra","year":"2013","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/dc08-1775","article-title":"Lipid and lipoprotein profiles in youth with and without type 1 diabetes: The SEARCH for diabetes in youth case-control study","volume":"32","author":"Guy","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-018-0802-0","article-title":"Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: A case control study","volume":"17","author":"Gourgari","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Ahmed, M.O., Byrne, R.E., Pazderska, A., Segurado, R., Guo, W., Gunness, A., Frizelle, I., Sherlock, M., Ahmed, K.S., and McGowan, A. (2020). HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: A cross-sectional study. Diabetologia.","DOI":"10.1007\/s00125-020-05320-3"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000011094","article-title":"High-density lipoprotein-cholesterol functionality and metabolic syndrome: Protocol for review and meta-analysis","volume":"97","author":"Roever","year":"2018","journal-title":"Medicine"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5223\/pghn.2020.23.3.189","article-title":"Novel insights into the pathogenesis and management of the metabolic syndrome","volume":"23","author":"Wang","year":"2020","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cvr\/cvu147","article-title":"HDL-mediated mechanisms of protection in cardiovascular disease","volume":"103","author":"Kontush","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.atherosclerosis.2015.07.019","article-title":"Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT","volume":"242","author":"Lucero","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.116.004808","article-title":"Association of cholesterol efflux capacity with clinical features of metabolic syndrome: Relevance to atherosclerosis","volume":"5","author":"Gall","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep27367","article-title":"Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: The CODAM study","volume":"6","author":"Annema","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2018.07.028","article-title":"Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease","volume":"277","author":"Gruppen","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Di Costanzo, A., Ronca, A., D\u2019erasmo, L., Manfredini, M., Baratta, F., Pastori, D., di Martino, M., Ceci, F., Angelico, F., and del Ben, M. (2020). Hdl-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (Nafld). Biomedicines, 8.","DOI":"10.3390\/biomedicines8120625"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/ATVBAHA.117.310212","article-title":"Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome","volume":"38","author":"Khan","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/13685538.2018.1479387","article-title":"Analysis of cardiovascular risk factors associated with serum testosterone levels according to the US 2011\u20132012 National Health and Nutrition Examination Survey","volume":"22","author":"Deng","year":"2019","journal-title":"Aging Male"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1210\/jc.2018-02027","article-title":"High-Density Lipoprotein Function Is Reduced in Patients Affected by Genetic or Idiopathic Hypogonadism","volume":"104","author":"Adorni","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1194\/jlr.M800362-JLR200","article-title":"Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux","volume":"50","author":"Sankaramarayanan","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1194\/jlr.M075648","article-title":"Influence of HDL particles on cell-cholesterol efflux under various pathological conditions","volume":"58","author":"Asztalos","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jacl.2018.04.013","article-title":"Sex Steroids Mediate Discrete Effects on HDL Cholesterol Efflux Capacity and Particle Concentration in Healthy Men","volume":"12","author":"Rubinow","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.steroids.2012.01.002","article-title":"Acute Sex Steroid Withdrawal Increases Cholesterol Efflux Capacity and HDL-Associated Clusterin in Men Katya","volume":"77","author":"Rubinow","year":"2012","journal-title":"Steroids"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1194\/jlr.P026005","article-title":"Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity","volume":"53","author":"Rubinow","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/ENDO:24:1:001","article-title":"Hypothyroidism as a risk factor for cardiovascular disease","volume":"24","author":"Biondi","year":"2004","journal-title":"Endocrine"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"E3355","DOI":"10.1210\/clinem\/dgaa411","article-title":"HDL cholesterol efflux capacity is impaired in severe short-term hypothyroidism despite increased HDL cholesterol","volume":"105","author":"Jia","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2013-3918","article-title":"Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS","volume":"99","author":"Roe","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12020-019-01911-2","article-title":"Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients","volume":"66","author":"Tedesco","year":"2019","journal-title":"Endocrine"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/humrep\/deu115","article-title":"Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL2 and HDL3","volume":"29","author":"Gidwani","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jsbmb.2006.02.007","article-title":"Fatty acid esterification of lipoprotein-associated estrone in human plasma and follicular fluid","volume":"100","author":"Miilunpohja","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/cen.13310","article-title":"Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome","volume":"86","author":"Dokras","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4330\/wjc.v12.i7.303","article-title":"MicroRNA sequences modulating inflammation and lipid accumulation in macrophage \u201cfoam\u201d cells: Implications for atherosclerosis","volume":"12","author":"Lightbody","year":"2020","journal-title":"World J. Cardiol."},{"key":"ref_175","unstructured":"Transporter, G.A., Panousis, C.G., and Zuckerman, S.H. (2011). Interferon-r Induces Downregulation of Tangier Disease. 2011, 1565\u20131571. Arterioscler. Thromb. Vasc. Biol., 1565\u20131571."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.cmet.2017.04.005","article-title":"Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity","volume":"25","author":"Westerterp","year":"2017","journal-title":"Cell Metab"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-02860-3","article-title":"High-density lipoproteins during sepsis: From bench to bedside","volume":"24","author":"Tanaka","year":"2020","journal-title":"Crit. Care"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.M059089","article-title":"Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity","volume":"56","author":"Vaisar","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15755-1","article-title":"Proteomic study revealed cellular assembly and lipid metabolism dysregulation in sepsis secondary to community-acquired pneumonia","volume":"7","author":"Sharma","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2012.02.032","article-title":"Inflammation modulates human HDL composition and function in vivo","volume":"222","author":"McGillicuddy","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1194\/jlr.P076463","article-title":"Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction","volume":"58","author":"Zimetti","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/ATVBAHA.108.178681","article-title":"HDL remodeling during the acute phase response","volume":"29","author":"Jahangiri","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/SHK.0000000000001030","article-title":"HDL Cholesterol Efflux is Impaired in Older Patients with Early Sepsis: A Subanalysis of a Prospective Pilot Study","volume":"50","author":"Guirgis","year":"2018","journal-title":"Shock"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1194\/jlr.M300250-JLR200","article-title":"Periodontitis decreases the antiatherogenic potency of high density lipoprotein","volume":"45","author":"Pussinen","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","article-title":"Cardiovascular disease in autoimmune rheumatic diseases","volume":"12","author":"Hollan","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: The impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1365-2362.2010.02361.x","article-title":"The versatility of HDL: A crucial anti-inflammatory regulator","volume":"40","author":"Poglitsch","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/978-3-319-09665-0_14","article-title":"Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions","volume":"224","author":"Montecucco","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/annrheumdis-2011-200493","article-title":"Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis","volume":"71","author":"Lee","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","article-title":"Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus","volume":"73","author":"Ronda","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.numecd.2014.01.006","article-title":"Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus","volume":"24","author":"Ammirati","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Quevedo-Abeledo, J.C., S\u00e1nchez-P\u00e9rez, H., Tejera-Segura, B., de Armas-Rillo, L., Armas-Gonz\u00e1lez, E., Machado, J.D., Gonz\u00e1lez-Gay, M.A., D\u00edaz-Gonz\u00e1lez, F., and Ferraz-Amaro, I. (2020). Differences in HDL-Cholesterol Efflux Capacity Between Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis. Arthritis Care Res., 3.","DOI":"10.1002\/acr.24407"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s10067-020-04961-4","article-title":"HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients","volume":"39","author":"Machado","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/rheumatology\/keaa038","article-title":"Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis","volume":"59","author":"Machado","year":"2020","journal-title":"Rheumatology"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MOL.0000000000000333","article-title":"Effect of inflammation on HDL structure and function","volume":"27","author":"Feingold","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10067-017-3896-y","article-title":"High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis","volume":"37","author":"Meriwether","year":"2018","journal-title":"Clin Rheumatol"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3899\/jrheum.141532","article-title":"Impaired antiatherogenic functions of high-density lipoprotein in patients with ankylosing spondylitis","volume":"42","author":"Gkolfinopoulou","year":"2015","journal-title":"J. Rheumatol."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Behl, T., Kaur, I., Sehgal, A., Zengin, G., Brisc, C., Brisc, M.C., Munteanu, M.A., Nistor-Cseppento, D.C., and Bungau, S. (2020). The lipid paradox as a metabolic checkpoint and its therapeutic significance in ameliorating the associated cardiovascular risks in rheumatoid arthritis patients. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249505"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.vph.2016.01.006","article-title":"Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis","volume":"81","author":"Naerr","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semarthrit.2016.03.004","article-title":"Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: Implications for the rheumatologist","volume":"46","author":"Kaplan","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.41293","article-title":"Biologics May Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Coronary Plaque Formation and Stabilizing High-Risk Lesions","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/annrheumdis-2013-204345","article-title":"Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study","volume":"74","author":"McInnes","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/annrheumdis-2011-201228","article-title":"HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab","volume":"72","author":"Raterman","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.39833","article-title":"Improvement in HDL Function in Early Rheumatoid Arthritis Patients Treated with Methotrexate Monotherapy or Combination Therapy in the TEAR Trial","volume":"69","author":"Lim","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.atherosclerosis.2018.04.003","article-title":"Remodiling of the HDL Proteome with Treatment Response to Abatacept or Adalimumab in the AMPLE Trial of Patients with Rheumatoid Arthritis","volume":"275","author":"Gugiu","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/a-0833-4627","article-title":"Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin\/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients","volume":"51","author":"Machado","year":"2019","journal-title":"Horm. Metab. Res."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Cacciapaglia, F., Perniola, S., Venerito, V., Anelli, M.G., H\u00e4rdfeldt, J., Fornaro, M., Moschetta, A., and Iannone, F. (2020). The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients. J. Clin. Rheumatol.","DOI":"10.1097\/RHU.0000000000001657"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/jid.2013.359","article-title":"Anti-psoriatic therapy recovers high-density lipoprotein composition and function","volume":"134","author":"Holzer","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_211","first-page":"34","article-title":"HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis","volume":"6","author":"Mani","year":"2016","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.39039","article-title":"Newly identified antiatherosclerotic activity of methotrexate and adalimumab: Complementary effects on lipoprotein function and macrophage cholesterol metabolism","volume":"67","author":"Ronda","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Greco, D., Gualtierotti, R., Agosti, P., Adorni, M.P., Ingegnoli, F., Rota, M., Bernini, F., Meroni, P.L., and Ronda, N. (2020). Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072157"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/heartjnl-2015-308953","article-title":"Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis","volume":"103","author":"Charakida","year":"2017","journal-title":"Heart"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Hunjadi, M., Lamina, C., Kahler, P., Bernscherer, T., Viikari, J., Lehtim\u00e4ki, T., K\u00e4h\u00f6nen, M., Hurme, M., Juonala, M., and Taittonen, L. (2020). HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-76146-7"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1194\/jlr.P069039","article-title":"HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: The Chicago Healthy Aging Study","volume":"58","author":"Mutharasan","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1194\/jlr.M600167-JLR200","article-title":"Age-related impairment of HDL-mediated cholesterol efflux","volume":"48","author":"Berrougui","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1194\/jlr.P079525","article-title":"Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians","volume":"59","author":"Zimetti","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Ritsch, A., Duerr, A., Kahler, P., Hunjadi, M., Stojakovic, T., Silbernagel, G., Scharnagl, H., Kleber, M.E., and M\u00e4rz, W. (2020). Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Biomedicines, 8.","DOI":"10.3390\/biomedicines8110524"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1016\/j.jacc.2018.09.080","article-title":"Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction","volume":"72","author":"Guerin","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCULATIONAHA.116.023712","article-title":"Mediterranean Diet Improves High-Density Lipoprotein Function in High-Cardiovascular-Risk Individuals: A Randomized Controlled Trial","volume":"135","author":"Elosua","year":"2017","journal-title":"Circulation"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jn\/nxy040","article-title":"Diets Low in Saturated Fat with Different Unsaturated Fatty Acid Profiles Similarly Increase Serum-Mediated Cholesterol Efflux from THP-1 Macrophages in a Population with or at Risk for Metabolic Syndrome: The Canola Oil Multicenter Intervention Trial","volume":"148","author":"Liu","year":"2018","journal-title":"J. Nutr."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3945\/jn.112.170993","article-title":"Acute consumption of walnuts and walnut components differentially affect postprandial lipemia, endothelial function, oxidative stress, and cholesterol efflux in humans with mild hypercholesterolemia","volume":"143","author":"Berryman","year":"2013","journal-title":"J. Nutr."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.atherosclerosis.2014.10.011","article-title":"Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia","volume":"237","author":"Tanaka","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jn\/nxy014","article-title":"Saturated Fats from Butter but Not from Cheese Increase HDL-Mediated Cholesterol Efflux Capacity from J774 Macrophages in Men and Women with Abdominal Obesity","volume":"148","author":"Brassard","year":"2018","journal-title":"J. Nutr."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/jn\/nxz313","article-title":"Replacing Saturated Fats with Unsaturated Fats from Walnuts or Vegetable Oils Lowers Atherogenic Lipoprotein Classes Without Increasing Lipoprotein(a)","volume":"150","author":"Tindall","year":"2020","journal-title":"J. Nutr."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.atherosclerosis.2018.12.017","article-title":"The effect of intakes of fish and Camelina sativa oil on atherogenic and anti-atherogenic functions of LDL and HDL particles: A randomized controlled trial","volume":"281","author":"Manninen","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0022-2275(20)31537-6","article-title":"Alcohol consumption stimulates early steps in reverse cholesterol transport","volume":"42","author":"Vermunt","year":"2001","journal-title":"J. Lipid Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/01.ALC.0000122763.30770.F5","article-title":"Effect of moderate alcohol consumption on parameters of reverse cholesterol transport in postmenopausal women","volume":"28","author":"Sierksma","year":"2004","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1194\/jlr.M400109-JLR200","article-title":"Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1","volume":"45","author":"Beulens","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_232","first-page":"1310","article-title":"Effects of alcohol on the major steps of reverse cholesterol transport","volume":"65","author":"Serdyuk","year":"2000","journal-title":"Biochemistry"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.metabol.2007.03.003","article-title":"Long-term ethanol consumption impairs reverse cholesterol transport function of high-density lipoproteins by depleting high-density lipoprotein sphingomyelin both in rats and in humans","volume":"56","author":"Marmillot","year":"2007","journal-title":"Metabolism"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1053\/meta.2000.17728","article-title":"High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function","volume":"49","author":"Rao","year":"2000","journal-title":"Metabolism"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOL.0000000000000568","article-title":"Effects of exercise on HDL functionality","volume":"30","author":"Barber","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ez, \u00c1., Soria-Florido, M.T., Casta\u00f1er, O., Pint\u00f3, X., Estruch, R., Salas-Salvad\u00f3, J., Corella, D., Alonso-G\u00f3mez, \u00c1., Mart\u00ednez-Gonz\u00e1lez, M.\u00c1., and Schr\u00f6der, H. (2020). Leisure time physical activity is associated with improved HDL functionality in high cardiovascular risk individuals: A cohort study. Eur. J. Prev. Cardiol.","DOI":"10.1177\/2047487320925625"},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Trakaki, A., Scharnagl, H., Trieb, M., Holzer, M., Hinghofer-Szalkay, H., Goswami, N., and Marsche, G. (2020). Prolonged bedrest reduces plasma high-density lipoprotein levels linked to markedly suppressed cholesterol efflux capacity. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-71921-y"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/HCO.0000000000000204","article-title":"Smoking cessation and the cardiovascular patient","volume":"30","author":"Prochaska","year":"2015","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3945\/an.116.014050","article-title":"Effects of dietary flavonoids on reverse cholesterol transport, HDL metabolism, and HDL function","volume":"8","author":"Millar","year":"2017","journal-title":"Adv. Nutr."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1210\/jc.2013-2845","article-title":"Anthocyanin supplementation improves HDL-Associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia","volume":"99","author":"Zhu","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.numecd.2020.05.002","article-title":"Functional pasta consumption in healthy volunteers modulates ABCG1-mediated cholesterol efflux capacity of HDL","volume":"30","author":"Favari","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.numecd.2018.04.010","article-title":"Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women","volume":"28","author":"Greco","year":"2018","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2147\/TCRM.S144121","article-title":"Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9","volume":"13","author":"Adorni","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jacl.2016.06.006","article-title":"Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses","volume":"10","author":"Kastelein","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jacc.2015.09.013","article-title":"Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib","volume":"66","author":"Nicholls","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/978-3-319-09665-0_19","article-title":"Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function","volume":"224","author":"Gomaraschi","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12944-020-01350-3","article-title":"Effect of niacin monotherapy on high density lipoprotein composition and function","volume":"19","author":"Gordon","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1194\/jlr.P024810","article-title":"Cellular cholesterol efflux and cholesterol loading capacity of serum: Effects of LDL-apheresis","volume":"53","author":"Adorni","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacl.2012.08.001","article-title":"Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis","volume":"7","author":"Nenseter","year":"2013","journal-title":"J. Clin. Lipidol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1194\/jlr.M024141","article-title":"Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia","volume":"53","author":"Orsoni","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1111\/bph.15213","article-title":"A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE\u2212\/\u2212 mice","volume":"177","author":"Gou","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jamacardio.2018.2112","article-title":"Effect of infusion of high-density lipoprotein mimetic containing recombinant apolipoprotein A-I Milano on coronary disease in patients with an acute coronary syndrome in the MILANO-PILOT trial: A randomized clinical trial","volume":"3","author":"Nicholls","year":"2018","journal-title":"JAMA Cardiol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2020.08.004","article-title":"No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels","volume":"311","author":"Zheng","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/ATVBAHA.114.303720","article-title":"CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects","volume":"34","author":"Gille","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Tricoci, P., D\u2019Andrea, D.M., Gurbel, P.A., Yao, Z., Cuchel, M., Winston, B., Schott, R., Weiss, R., Blazing, M.A., and Cannon, L. (2015). Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial. J. Am. Heart Assoc., 4.","DOI":"10.1161\/JAHA.115.002171"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCULATIONAHA.116.025687","article-title":"Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, after Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)","volume":"134","author":"Gibson","year":"2016","journal-title":"Circulation"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/3\/574\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:33:44Z","timestamp":1760160824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/3\/574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":257,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["cells10030574"],"URL":"https:\/\/doi.org\/10.3390\/cells10030574","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]}}}